Immunohistochemical results from percutaneous liver biopsy indicated metastatic SCLC.<h4>Results</h4>After resistance to ALK-TKIs and transformation to SCLC, the patient received chemotherapy combined with immunotherapy for SCLC, but the patient's disease progressed rapidly. This evidence concerns the gene ALK and small cell lung carcinoma.